Does Rallies show Form 4 insider transactions for CVS?

Yes. Rallies tracks CVS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CVS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CVS. It does not provide personalized investment advice.

CVS (CVS Health) Stock Analysis - Insider Trades

CVS Health (CVS) is a publicly traded Healthcare sector company. As of May 20, 2026, CVS trades at $93.39 with a market cap of $122.48B and a P/E ratio of 14.37. CVS moved -0.73% today. Year to date, CVS is +17.53%; over the trailing twelve months it is +50.02%. Its 52-week range spans $43.56 to $98.43. Analyst consensus is strong buy with an average price target of $102.35. Rallies surfaces CVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CVS stock inside the company?

Recent CVS insider activity includes Mandadi Tilak sold 69.55K, Finucane Anne A. sold 7.50K, SANSONE GUY P bought 1.57K, Nelson Steven H bought 24, and CAPOZZI HEIDI B bought 35. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CVS Key Metrics

Key financial metrics for CVS
Metric	Value
Price	$93.39
Market Cap	$122.48B
P/E Ratio	14.37
EPS	$6.49
Dividend Yield	0.67%
52-Week High	$98.43
52-Week Low	$43.56
Volume	6.00M
Avg Volume	0
Revenue (TTM)	$357.78B
Net Income	$8.37B
Gross Margin	39.32%

Recent CVS Insider Trades

Mandadi Tilak sold 69.55K (~$6.23M) on May 8, 2026.
Finucane Anne A. sold 7.50K (~$532.65K) on Aug 20, 2025.
SANSONE GUY P bought 1.57K (~$100.01K) on Jun 5, 2025.
Nelson Steven H bought 24 (~$1.29K) on Jan 23, 2025.
CAPOZZI HEIDI B bought 35 (~$1.99K) on Oct 23, 2024.

Latest CVS News

CVS Health Invests $292M in Veteran-Owned Businesses and Expands Military Family Programs — May 20, 2026
CVS Health invests $20 billion in digital health tools after survey finds 58% of seniors struggle — May 18, 2026
CVS Health, WGU Launch Online Pre-Pharmacy Program with $3,989 Term Tuition — May 14, 2026
MinuteClinic Weight-Loss Program Posts 85% Three-Month Success Across 49 States, Primary Care at 60% of Clinics — May 13, 2026
CVS jumps as TD Cowen lifts price target to $110, keeps buy — May 12, 2026

CVS Analyst Consensus

17 analysts cover CVS: 0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $102.35.

Common questions about CVS

Who is trading CVS stock inside the company?: Recent CVS insider activity includes Mandadi Tilak sold 69.55K, Finucane Anne A. sold 7.50K, SANSONE GUY P bought 1.57K, Nelson Steven H bought 24, and CAPOZZI HEIDI B bought 35. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CVS?: Yes. Rallies tracks CVS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CVS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CVS. It does not provide personalized investment advice.